Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Cancer Pain, Quality of Life, Pain, Acute, Cannabis Use

In brief

This phase 2 multicenter clinical trial assess the safety and efficacy of inhaled PPP001 to relieve the pain in 78 advanced cancer patients with uncontrolled symptoms. This is a 4-week treatment period study followed by an open label period of 1 year.

Key facts

Study ID
NCT04042545
Run by
Tetra Bio-Pharma
People needed
78
Starts
2020-07-30
Expected to finish
2022-09-01
Last updated by the study team
2021-09-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.